Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
Biotech
Amgen disappears lung disease program after phase 2 fail
Amgen is discontinuing a lung disease program after its investigational small molecule failed to hit any primary or secondary endpoints.
Gabrielle Masson
Oct 30, 2024 5:59pm
Dexcom posts mixed-bag earnings report amid Stelo rollout
Oct 25, 2024 1:30pm
Glooko collects $100M, and a new CEO, to boost diabetes platform
Oct 10, 2024 10:30am
Medtronic recalls MiniMed insulin pumps over drained batteries
Oct 8, 2024 12:00pm
Lilly posts more positive data on once-weekly insulin prospect
Sep 11, 2024 2:05pm
Over-the-counter CGM market grows, with Abbott’s Lingo debut
Sep 5, 2024 12:00pm
